Pearson

Assessments for Educational, Clinical and Psychological Use



Adult Personality


Child/Adolescent
Personality & Behavior



Biopsychosocial
Issues



Career Interests
& Skills



Achievement, Development
& Cognitive Function

 
 

Home    >   Press Releases   >   Wall Street Journal Story

this site all Assessment group

Response to The Wall Street Journal story on the FBS (Symptom Validity) Scale

Pearson and the University of Minnesota Press are aware of an article about the FBS (Symptom Validity) Scale that appeared in The Wall Street Journal on March 5, in which items of the FBS (Symptom Validity) Scale were reproduced in the story and in a link to the newspaper’s website. Since then, we have been able to have the link showing FBS (Symptom Validity) Scale items removed from the newspaper’s website and are currently evaluating the impact of the article.

If you are a clinical professional and aware of other places where the FBS (Symptom Validity) Scale has been illegally reproduced, either in publications, websites, chat rooms, or blogs, please:

     Click here to send us an email with the details.



To Reach a Client Relations Representative

Call: 1-800-627-7271
7 AM-6 PM CST
Fax: 1-800-632-9011 or 952-681-3299
E-Mail: pearsonassessments@pearson.com


News

ArrowPress Releases
ArrowMedical Newsletter
ArrowTrade Shows & Events
ArrowCase Studies - Profiles

Adult Personality - Adolescent Personality - Biopsychosocial - Careers - Achievement/Cognitive
Home - News - Products A to Z - Ordering - Resources - Scoring - Support - Contact